141 related articles for article (PubMed ID: 17227616)
1. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
Marijani R; Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
[TBL] [Abstract][Full Text] [Related]
2. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug.
Shaik MS; Haynes A; McSween J; Ikediobi O; Kanikkannan N; Singh M
J Aerosol Med; 2002; 15(3):261-70. PubMed ID: 12396414
[TBL] [Abstract][Full Text] [Related]
3. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
[TBL] [Abstract][Full Text] [Related]
4. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
5. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
6. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
7. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
Gupta A; Stein SW; Myrdal PB
J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
[TBL] [Abstract][Full Text] [Related]
8. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
9. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
Abdou EM; Kandil SM; Morsi A; Sleem MW
Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
[TBL] [Abstract][Full Text] [Related]
11. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.
Fulzele SV; Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2006 Mar; 58(3):327-36. PubMed ID: 16536899
[TBL] [Abstract][Full Text] [Related]
13. Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability.
Tzou TZ; Pachuta RR; Coy RB; Schultz RK
J Pharm Sci; 1997 Dec; 86(12):1352-7. PubMed ID: 9423144
[TBL] [Abstract][Full Text] [Related]
14. Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a.
Williams RO; Liu J; Koleng JJ
Pharm Res; 1997 Apr; 14(4):438-43. PubMed ID: 9144728
[TBL] [Abstract][Full Text] [Related]
15. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
16. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
McCabe JC; Koppenhagen F; Blair J; Zeng XM
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
[TBL] [Abstract][Full Text] [Related]
17. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
[TBL] [Abstract][Full Text] [Related]
18. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments.
Martin AR; Kwok DY; Finlay WH
J Aerosol Med; 2005; 18(2):218-24. PubMed ID: 15966776
[TBL] [Abstract][Full Text] [Related]
19. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
20. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
Berry J; Kline LC; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
